| Issue Date | Title | Author(s) |
| 2024-01-05 | Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice. | Hilton, JBW; Kysenius, K; Liddell, JR; Mercer, SW; Hare, DJ; Buncic, G; Paul, B; Wang, Y; Murray, SS; Kilpatrick, TJ; White, AR; Donnelly, PS; Crouch, PJ |
| 2024-03-11 | Evidence for disrupted copper availability in human spinal cord supports CuII(atsm) as a treatment option for sporadic cases of ALS. | Hilton, JBW; Kysenius, K; Liddell, JR; Mercer, SW; Paul, B; Beckman, JS; McLean, CA; White, AR; Donnelly, PS; Bush, AI; Hare, DJ; Roberts, BR; Crouch, PJ |
| 2024-09 | Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis. | Hilton, JBW; Kysenius, K; Liddell, JR; Mercer, SW; Rautengarten, C; Hare, DJ; Buncic, G; Paul, B; Murray, SS; McLean, CA; Kilpatrick, TJ; Beckman, JS; Ayton, S; Bush, AI; White, AR; Roberts, BR; Donnelly, PS; Crouch, PJ |
| 2024-02-05 | Microglial ferroptotic stress causes non-cell autonomous neuronal death. | Liddell, JR; Hilton, JBW; Kysenius, K; Billings, JL; Nikseresht, S; McInnes, LE; Hare, DJ; Paul, B; Mercer, SW; Belaidi, AA; Ayton, S; Roberts, BR; Beckman, JS; McLean, CA; White, AR; Donnelly, PS; Bush, AI; Crouch, PJ |
| 2014-01-01 | Oral treatment with Cu<sup>II</sup>(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis | Roberts, BR; Lim, NKH; McAllum, EJ; Donnelly, PS; Hare, DJ; Doble, PA; Turner, BJ; Price, KA; Lim, SC; Paterson, BM; Hickey, JL; Rhoads, TW; Williams, JR; Kanninen, KM; Hung, LW; Liddell, JR; Grubman, A; Monty, JF; Llanos, RM; Kramer, DR; Mercer, JFB; Bush, AI; Masters, CL; Duce, JA; Li, QX; Beckman, JS; Barnham, KJ; White, AR; Crouch, PJ |
